Literature DB >> 24475401

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.

Mehrdad Solati1, Hamid-Reza Mahboobi2.   

Abstract

Entities:  

Keywords:  Chronic renal failure; Dyslipidemia; Paraoxonase

Year:  2012        PMID： 24475401      PMCID： PMC3886149          DOI： 10.5812/nephropathol.8106

Source DB:  PubMed          Journal:  J Nephropathol        ISSN： 2251-8363


× No keyword cloud information.
  19 in total

1.  Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure.

Authors:  Éva Varga; Ildikó Seres; Mariann Harangi; István Kárpáti; Péter Koncsos; Ferenc Sztanek; György Paragh
Journal:  Kidney Blood Press Res       Date:  2012-02-23       Impact factor: 2.687

2.  Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Authors:  Maria Fernanda Martínez-Salazar; Damianys Almenares-López; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Alina Juantorena-Ugás; Camilo Ríos; Antonio Monroy-Noyola
Journal:  Genes Nutr       Date:  2011-03-25       Impact factor: 5.523

3.  Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Mehmet Davutoğlu; Meki Bilici; Murat Tutanç; Ali Güneş
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 4.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 5.  Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

Authors:  N D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2006-02

6.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

7.  Serum paraoxonase activity and protein thiols in chronic renal failure patients.

Authors:  M Prakash; J K Shetty; L Rao; S Sharma; A Rodrigues; R Prabhu
Journal:  Indian J Nephrol       Date:  2008-01

8.  Serum paraoxonase activity before and after treatment of thyrotoxicosis.

Authors:  Farbod Raiszadeh; Mehrdad Solati; Arash Etemadi; Fereidoun Azizi
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

9.  Decrease of serum paraoxonase activity in chronic renal failure.

Authors:  T F Dantoine; J Debord; J P Charmes; L Merle; P Marquet; G Lachatre; C Leroux-Robert
Journal:  J Am Soc Nephrol       Date:  1998-11       Impact factor: 10.121

10.  Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.

Authors:  Alejandro Gugliucci; Nicole Lunceford; Eriko Kinugasa; Hiroaki Ogata; John Schulze; Satoshi Kimura
Journal:  Clin Chim Acta       Date:  2007-06-23       Impact factor: 3.786
View more
  14 in total

1.  Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients.

Authors:  Hamid Nasri
Journal:  Jundishapur J Microbiol       Date:  2014-02-01       Impact factor: 0.747

2.  Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study.

Authors:  Mahmoud Rafieian-Kopaei; Azar Baradaran; Alireza Merrikhi; Mehdi Nematbakhsh; Yahya Madihi; Hamid Nasri
Journal:  Int J Prev Med       Date:  2013-03

3.  Association of serum uric acid with proteinuria in type 2 diabetic patients.

Authors:  Saeed Behradmanesh; Mohammad Karami Horestani; Azar Baradaran; Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-01       Impact factor: 1.852

4.  Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.

Authors:  Hamid Nasri
Journal:  Cell J       Date:  2013-11-20       Impact factor: 2.479

5.  Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial.

Authors:  Azar Baradaran
Journal:  Daru       Date:  2013-03-08       Impact factor: 3.117

6.  Renoprotective effects of metformin.

Authors:  Running Hamid Nasri
Journal:  Daru       Date:  2013-05-16       Impact factor: 3.117

7.  World kidney day 2013: acute kidney injury; a public health aware.

Authors:  Hamid Nasri
Journal:  Iran J Public Health       Date:  2013-03-01       Impact factor: 1.429

8.  Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients.

Authors:  Hamid Nasri; Yahya Madihi; Alireza Merrikhi; Allaleh Gheissari; Azar Baradaran; Soleiman Kheiri; Mahmoud Rafieian-Kopaei
Journal:  Int J Prev Med       Date:  2013-05

9.  Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?

Authors:  Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

10.  Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits.

Authors:  Mahbubeh Setorki; Mahmoud Rafieian-Kopaei; Alireza Merikhi; Esfandiar Heidarian; Najmeh Shahinfard; Roya Ansari; Hamid Nasri; Nafiseh Esmael; Azar Baradaran
Journal:  Int J Prev Med       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.